SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-044302
Filing Date
2011-08-05
Accepted
2011-08-05 16:30:58
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-14113_110q.htm 10-Q 829834
2 EX-10.5 a11-14113_1ex10d5.htm EX-10.5 96231
3 EX-31.1 a11-14113_1ex31d1.htm EX-31.1 9736
4 EX-31.2 a11-14113_1ex31d2.htm EX-31.2 9681
5 EX-32.1 a11-14113_1ex32d1.htm EX-32.1 5003
6 EX-32.2 a11-14113_1ex32d2.htm EX-32.2 5032
  Complete submission text file 0001104659-11-044302.txt   2278269

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bpax-20110630.xml EX-101.INS 161333
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpax-20110630.xsd EX-101.SCH 12168
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpax-20110630_cal.xml EX-101.CAL 24599
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpax-20110630_def.xml EX-101.DEF 76658
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpax-20110630_lab.xml EX-101.LAB 188865
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpax-20110630_pre.xml EX-101.PRE 97985
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 111014583
SIC: 2836 Biological Products, (No Diagnostic Substances)